本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

14.60
+1.4511.03%
盘后14.700.1000+0.68%16:40 EDT
成交量:186.81万
成交额:2,686.78万
市值:21.20亿
市盈率:-5.68
高:14.66
开:13.41
低:13.41
收:13.15
数据加载中...
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]